Effects of captopril in animal models of hypertension.
D000311:Adrenal Glands / Q000378:metabolism; D000450:Aldosterone / Q000378:metabolism; D000803:Angiotensin I / Q000378:metabolism; D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D001158:Arteries / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D001920:Bradykinin / Q000378:metabolism; D002216:Captopril / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D006439:Hemodynamics / Q000187:drug effects; D006830:Hydralazine / Q000494:pharmacology; D006852:Hydrochlorothiazide / Q000494:pharmacology; D006973:Hypertension / Q000188:drug therapy*; D007610:Kallikreins / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D011392:Proline / Q000031:analogs & derivatives*; D011453:Prostaglandins / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D012083:Renin / Q000378:metabolism; D012964:Sodium / Q000378:metabolism
D011453:Prostaglandins; D006852:Hydrochlorothiazide; D000804:Angiotensin II; D006830:Hydralazine; D000450:Aldosterone; D000803:Angiotensin I; D011392:Proline; D002216:Captopril; D012964:Sodium; D007610:Kallikreins; D012083:Renin; D001920:Bradykinin